Wegovy’s New Subscription Model Opens Doors for PatientsBusiness PenMarch 31, 2026April 22, 2026 March 31, 2026April 22, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk (NYSE: NVO) deals in diabetes and obesity medications. Wegovy stands out as one of its key products....